|
LEPROT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.382200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.343600E-03 |
| Normal-vs-Stage2 |
1.185070E-04 |
| Normal-vs-Stage3 |
7.391100E-04 |
| Normal-vs-Stage4 |
5.623600E-04 |
| Stage1-vs-Stage2 |
7.421800E-02 |
| Stage1-vs-Stage3 |
1.798210E-01 |
| Stage1-vs-Stage4 |
1.375770E-01 |
| Stage2-vs-Stage3 |
3.495400E-01 |
| Stage2-vs-Stage4 |
5.777600E-01 |
| Stage3-vs-Stage4 |
7.354600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.998400E-04 |
| Normal-vs-AfricanAmerican |
1.707390E-01 |
| Normal-vs-Asian |
7.653600E-02 |
| Caucasian-vs-AfricanAmerican |
5.557600E-01 |
| Caucasian-vs-Asian |
7.993800E-01 |
| AfricanAmerican-vs-Asian |
7.628600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.97909999999757E-05 |
| Normal-vs-Female |
1.643530E-03 |
| Male-vs-Female |
4.591500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.309700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.199500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.09059999999317E-05 |
| Normal-vs-Age(81-100Yrs) |
1.692340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.407900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.864300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.040800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.006600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.907800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.668800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.462000E-01 |
| Classical-VS-Follicular |
3.63410002091058E-09 |
| Classical-VS-Other |
8.371600E-02 |
| Classical-VS-Normal |
3.986300E-02 |
| Tall-VS-Follicular |
6.879900E-03 |
| Tall-VS-Other |
1.081600E-01 |
| Tall-VS-Normal |
1.510150E-02 |
| Follicular-VS-Other |
8.670400E-01 |
| Follicular-VS-Normal |
7.99959987141108E-10 |
| Other-VS-Normal |
2.615600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70150000003522E-06 |
| Normal-vs-N1 |
2.048000E-02 |
| N0-vs-N1 |
4.437800E-01 |
|
|
